Start › Przewlekła białaczka limfocytowa › Karolina Północna › Durham
Badania kliniczne dla Przewlekła białaczka limfocytowa w mieście Durham, NC
27 badań dla Przewlekła białaczka limfocytowa szuka uczestników w ośrodkach w mieście Durham i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
RekrutacjaFaza 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi dalej
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Durham VA Medical Center, Durham
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RekrutacjaFaza 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi dalej
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 mi dalej
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
RekrutacjaFaza 3
- University of North Carolina At Chapel Hill, Chapel Hill · 10 mi dalej
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
RekrutacjaFaza 3
- Duke University Medical Center, Durham
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RekrutacjaFaza 3
- Duke University Medical Center, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · 10 mi dalej
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekrutacjaFaza 3
- Duke University, Durham
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RekrutacjaFaza 2
- Duke University, Durham
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
RekrutacjaFaza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi dalej
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
RekrutacjaFaza 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · 10 mi dalej
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekrutacjaFaza 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi dalej
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
RekrutacjaFaza 2
- Research Site, Durham
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
RekrutacjaFaza 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi dalej
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekrutacjaFaza 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Rekrutacja
- North Carolina Basnight Cancer Hospital, Chapel Hill · 10 mi dalej
Registry of Older Patients With Cancer
RekrutacjaBadanie obserwacyjne
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi dalej
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RekrutacjaFaza 1
- University of North Carolina, Chapel Hill · 10 mi dalej
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
RekrutacjaFaza 4
- Duke University Medical Center, Durham
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
RekrutacjaFaza 4
- Duke University Medical Center, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
RekrutacjaFaza 1
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
RekrutacjaFaza 2
- University of North Carolina /ID# 233313, Chapel Hill · 10 mi dalej
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
RekrutacjaFaza 2
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi dalej
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
RekrutacjaFaza 1
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RekrutacjaBadanie obserwacyjne
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi dalej
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
RekrutacjaFaza 2
- Durham VA Medical Center, Durham, NC, Durham
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekrutacjaFaza 1
- University of North Carolina, Chapel Hill · 10 mi dalej
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
RekrutacjaFaza 1
- Duke University, Durham
Badania dla Przewlekła białaczka limfocytowa w innych miastach
- Boston, MA31 badań
- Columbus, OH28 badań
- Washington, DC22 badań
- Seattle, WA20 badań
- Rochester, MN19 badań
- New York City, NY18 badań
- Houston, TX17 badań
- Baldwin Park, CA16 badań
- Milwaukee, WI15 badań
- Cincinnati, OH14 badań
- Chicago, IL14 badań
- Nashville, TN13 badań
Inne badania w mieście Durham
- Rak piersi63 badań
- Nowotwory (wszystkie typy)58 badań
- Niedrobnokomórkowy rak płuca39 badań
- Szpiczak mnogi37 badań
- Nowotwór przerzutowy33 badań
- Ostra białaczka szpikowa33 badań
- Rak płuc32 badań
- Rak prostaty32 badań
- Rak jelita grubego i odbytnicy28 badań
- Rak jajnika27 badań
- Niewydolność serca26 badań
- Rak trzustki24 badań
Źródło: ClinicalTrials.gov, dane pobrane 5 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.